Development of atropine sulphate nasal drops and its pharmacokinetic and safety evaluation in healthy human volunteers

Environmental Toxicology and Pharmacology

Volumn 27, Issue 2, 2009, Pages 206-211

  Rajpal, Sheetal ^b   Mittal, Gaurav ^a   Sachdeva, Ruchi ^a   Chhillar, Mitrabasu ^a   Ali, Rashid ^a   Agrawal, Shyam Sunder ^b   Kashyap, Ravi ^a   Bhatnagar, Aseem ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

Author keywords

Antidote; Atropine sulphate nasal drops; Chitosan; Organophosphorous poisoning

Indexed keywords

ANTIDOTE; ATROPINE; CHITOSAN; NERVE GAS ANTIDOTE; NOSE DROPS; ORGANOPHOSPHATE INSECTICIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOLOGICAL WARFARE AGENT; CORRELATION ANALYSIS; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; HEART RATE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PUPIL; QUANTITATIVE ANALYSIS; RADIOMETRY; RECOMMENDED DRUG DOSE; TERRORISM;

EID: 59849126087     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2008.10.007     Document Type: Article

References (29)

1. Albuquerque E.X., Pereira E.F., Aracava Y., Fawcett W.P., Oliveira M., Randall W.R., Hamilton T.A., Kan R.K., Romano Jr. J.A., and Adler M. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 13220-13225
2. Allen C.J., and Campbell A.H. Comparison of inhaled atropine sulphate and atropine methonitrate. Thorax 35 (1980) 932-935
3. Artursson P., Lindmark T., Davis S.S., and Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11 (1994) 1358-1361
4. Bajgar J. Organophosphates nerve agents poisoning: mechanism of action, diagnosis, prophylaxis and treatment. Adv. Clin. Chem. 38 (2004) 151-216
5. Bentur Y., Layish I., Krivoy A., Berkovitch M., Rotman E., Bar Haim S., Yehezkelli Y., and Kozer E. Civilian adult self-injections of atropine-trimedoxime (TMB4) auto-injectors. Clin. Toxicol. 44 (2006) 301-306
6. Berghem L., Bergman U., Schildt B., and Sörbo B. Plasma atropine concentrations determined by radioimmunoassay after single-dose i.v. and i.m. administration. Br. J. Anaesth. 52 (1980) 597-601
7. Davis S.S., Hardy J.G., Newman S.P., and Wilding I.R. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur. J. Nucl. Med. 19 (1992) 971-986
8. Dodane V., Khan M.A., and Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 182 (1999) 21-32
9. Dunn M.A., Hackley B.E., and Sidell F.R. Pretreatment for nerve agent exposure. In: Sidell F.R., Takafuji E.T., and Franz D.R. (Eds). Medical Aspects of Chemical and Biological Warfare (1997), Borden Institute, Washington 181-196
10. Ecobichon D.J. Toxic effects of pesticides. In: Klaassen C.D. (Ed). Toxicology (2001), McGraw-Hill, New York 763-768
11. Georgitis J.W. Nasal atropine sulphate-efficacy and safety of 0 050% and 0. 075% solutions for severe rhinorrhea. Arch. Otolaryngol. Head Neck Surg. 124 (1998) 916-920
12. Gervais H.W., el Gindi M., Radermacher P.R., Volz-Zang C., Palm D., Duda D., and Dick W.F. Plasma concentration following oral and intramuscular atropine in children and their clinical effects. Paediatr. Anaesth. 7 (1997) 13-18
13. Illum L., Farraj N.D., and Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11 (1994) 1186-1189
14. Illum L. Bioadhesive formulations for nasal peptide delivery. Bioadhesive Drug Delivery Systems (1999), Marcel Dekker, New York pp. 507-541
15. Kehe C.R., Lasseter K.C., Miller N.C., Wick K.A., Shamblen E.C., Ekholm B.P., Sandahl J.H., Chang S.F., Goldlust M.B., and Kvam D.C. Comparative absorption of atropine from a metered dose inhaler and an intramuscular injection. Ther. Drug Monit. 14 (1992) 132-134
16. Luessen H.L., De Leeuw B.J., Langemeyer M., De Boer A.G., Verhoef J.C., and Junginger H.E. Mucoadhesive polymers in peroral peptide drug delivery. IV: Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res. 13 (1996) 1668-1672
17. Marrs T.C., Rice P., and Vale J.A. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol. Rev. 25 (2006) 297-323
18. Pope C., Karanth S., and Liu J. Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of common mechanism of action. Environ. Toxicol. Pharmacol. 19 (2005) 433-446
19. Reutter S. Hazards of chemical weapons released during war: new perspectives. Environ. Health Perspect. 107 (1999) 985-990
20. Sidell F. Nerve agents. In: Sidell F.R., Takafuji E.T., and Franz D.R. (Eds). Medical Aspects of Chemical and Biological Warfare (1997), Borden Institute, Washington 129-179
21. Soane R.J., Frier M., Perkins A.C., Jones N.S., Davis S.S., and Illum L. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int. J. Pharm. 178 (1999) 55-65
22. Soane R.J., Hinchcliffe M., Davis S.S., and Illum L. Clearance characteristics of chitosan based formulations in the sheep nasal cavity. Int. J. Pharm. 217 (2001) 183-191
23. Sogias I.A., Williams A.C., and Khutoryanskiy V.V. Why is chitosan mucoadhesive?. Biomacromolecules 9 (2008) 1837-1842
24. Singh A.K., Bhardwaj N., and Bhatnagar A. Pharmacoscintigraphy: an unexplored modality in India. Ind. J. Pharm. Sci. 66 (2004) 18-25
25. Türker S., Onur E., and Ozer Y. Nasal route and drug delivery systems. Pharm. World Sci. 26 (2004) 137-142
26. Ugwoke M.I., Agu R.U., Verbeke N., and Kinget R. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv. Drug Deliv. Rev. 57 (2005) 1640-1665
27. Vesela S., Kuca K., and Jun D. Daphnia intoxicated by nerve agent tabun can be treated using human antidotes. Environ. Toxicol. Pharmacol. 25 (2008) 329-333
28. Volans A.P. Sarin: guidelines on the management of victims of a nerve gas attack. J. Accid. Emerg. Med. 13 (1996) 202-206
29. Wilding I.R., Coupe A.J., and Davis S.S. The role of gamma-scintigraphy in oral drug delivery. Adv. Drug Deliv. Rev. 46 1-3 (2001) 103-124